These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)]. Panel de expertos de Gesida y Plan Nacional sobre el Sida Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124 [TBL] [Abstract][Full Text] [Related]
6. How testing for HIV resistance influences therapeutic decision making. Analysis of a sample of 600 clinicians. Mascolini M; Wensing AM; Boucher CA IAPAC Mon; 2001 Mar; 7(3):85-90. PubMed ID: 11697306 [No Abstract] [Full Text] [Related]
7. Replication capacity, biological phenotype, and drug resistance of HIV strains isolated from patients failing antiretroviral therapy. Nicastri E; Sarmati L; d'Ettorre G; Palmisano L; Parisi SG; Uccella I; Rianda A; Concia E; Vullo V; Vella S; Andreoni M J Med Virol; 2003 Jan; 69(1):1-6. PubMed ID: 12436471 [TBL] [Abstract][Full Text] [Related]
8. [Epidemiology of primary drug resistance in chronically HIV-infected patients in Nordrhein-Westfalen, Germany, 2001-2005]. Oette M; Kaiser R; Däumer M; Fätkenheuer G; Rockstroh JK; Knechten H; Mitrenga D; Beerenwinkel N; Sagir A; Pfister H; Häussinger D Dtsch Med Wochenschr; 2007 May; 132(18):977-82. PubMed ID: 17457780 [TBL] [Abstract][Full Text] [Related]
9. Genotypic resistance tests for the management of structured therapeutic interruptions after multiple drug failure. Montroni M; Monforte AD Scand J Infect Dis Suppl; 2003; 106():79-81. PubMed ID: 15000591 [TBL] [Abstract][Full Text] [Related]
10. HAART is cost-effective and improves outcomes. Valenti WM AIDS Read; 2001 May; 11(5):260-2. PubMed ID: 11392694 [TBL] [Abstract][Full Text] [Related]
12. Impact of drug resistance genotypes on CD4+ counts and plasma viremia in heavily antiretroviral-experienced HIV-infected patients. Rodes B; García F; Gutierrez C; Martinez-Picado J; Aguilera A; Saumoy M; Vallejo A; Domingo P; Dalmau D; Ribas MA; Blanco JL; Pedreira J; Perez-Elias MJ; Leal M; de Mendoza C; Soriano V; J Med Virol; 2005 Sep; 77(1):23-8. PubMed ID: 16032728 [TBL] [Abstract][Full Text] [Related]
13. Long-term analysis of the resistance development in HIV-1 positive patients treated with protease and reverse transcriptase inhibitors: correlation of the genotype and disease progression. Václavíková J; Weber J; Machala L; Reinis M; Linka M; Brůcková M; Vandasová J; Stanková M; Konvalinka J Acta Virol; 2005; 49(1):29-36. PubMed ID: 15929396 [TBL] [Abstract][Full Text] [Related]
14. Development of HIV with drug resistance after CD4 cell count-guided structured treatment interruptions in patients treated with highly active antiretroviral therapy after dual-nucleoside analogue treatment. Nuesch R; Ananworanich J; Sirivichayakul S; Ubolyam S; Siangphoe U; Hill A; Cooper D; Lange J; Phanuphak P; Ruxrungtham K Clin Infect Dis; 2005 Mar; 40(5):728-34. PubMed ID: 15714420 [TBL] [Abstract][Full Text] [Related]
15. Genotypic resistance tests in the management of the HIV-infected patient at virological failure. Aceti A; Carosi G Scand J Infect Dis Suppl; 2003; 106():61-6. PubMed ID: 15000587 [TBL] [Abstract][Full Text] [Related]
16. Genotypic resistance tests for the clinical management of patients with primary HIV infection. Narciso P; Lazzarin A Scand J Infect Dis Suppl; 2003; 106():66-70. PubMed ID: 15000588 [TBL] [Abstract][Full Text] [Related]
18. Incorporating drug-resistance measurements into the clinical management of HIV-1 infection. Zolopa AR J Infect Dis; 2006 Sep; 194 Suppl 1():S59-64. PubMed ID: 16921474 [TBL] [Abstract][Full Text] [Related]
19. Efficacy of antiretroviral therapy programs in resource-poor settings: a meta-analysis of the published literature. Ivers LC; Kendrick D; Doucette K Clin Infect Dis; 2005 Jul; 41(2):217-24. PubMed ID: 15983918 [TBL] [Abstract][Full Text] [Related]
20. Impact of genotypic resistance testing on selection of salvage regimen in clinical practice. Haupts S; Ledergerber B; Böni J; Schüpbach J; Kronenberg A; Opravil M; Flepp M; Speck RF; Grube C; Rentsch K; Weber R; Günthard HF; Antivir Ther; 2003 Oct; 8(5):443-54. PubMed ID: 14640392 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]